As we close out 2025, thank you to our editorial board members, authors, reviewers, staff, & readers for advancing CV science and care. In 2026, #JACCJournals will continue elevating impactful research & improving patient outcomes 🌎 Here’s to a new year of advancing heart health together! 🫀🎆

Among patient with echo showing severe aortic stenosis, 74.3% of men had it in their problem list, compared to 64.1% for women. www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social #cardiosky

#ACCMember Sections were responsible for 16 #JACC publications in 2025. 📚 Learn more about how the Sections are making an impact and get involved: https://bit.ly/3KBA4va #CardioSky #MedSky @jaccjournals.bsky.social

Stay ahead of what’s shaping cardiovascular care in 2026. #JACC, the ACC’s flagship journal, delivers cutting-edge research, clinical guidelines, and expert perspectives—straight to your inbox. Subscribe to FREE JACC email alerts and stay informed: https://bit.ly/4pCcAF8 #CardioSky

❄️ Happy Holidays to the #JACCJournals editorial board members, authors, reviewers, staff, and readers and best wishes for a successful and healthy 2026 ahead! ❤️🩺

📈 Looking back at 2025 with #JACCCardioOnc! Explore our interactive Year in Review to see the journal’s global reach, latest impact factor, and most read & downloaded articles. Discover the research shaping #CardioOnc today: https://bit.ly/4p6wV4k #CardioSky #MedSky

Los Angeles residents saw significant rises in cardiopulmonary illness in the 3 months after the Jan 2025 Eaton & Palisades wildfires, per a study in #JACC. Findings are based on Cedars-Sinai ED data compared with the same period in 2018–2024. https://bit.ly/3YCJUjv #CardioSky

2025 ACC/AHA/Multisociety #ClinicalGuideline on #ACHD highlights practice-changing recommendations for caring for a diverse ACHD population. Explore the Guideline-at-a-Glance in #JACC to accelerate adoption in practice: https://bit.ly/4pRFGAE #CardioSky

The ACC & AHA, along with several other leading medical associations, have issued a new guideline for #ACHD, updating recommendations for monitoring, counseling, & treatment based on 2017–2024 evidence & replacing the 2018 guidance Get the details in #JACC: https://bit.ly/3Y4KM0d #CardioSky

With the US FDA approving a growing number of products that can perform quantitative coronary plaque analysis (QCPA), a new ACC Scientific Statement provides consensus recommendations on the appropriate use of QCPA in clinical practice Get the details in #JACCIMG: https://bit.ly/3MRSd8x #CardioSky

New ACC Scientific Statement on the management of PAD in adults w/ #diabetes adds context to the 2024 ACC/AHA Lower Extremity PAD Guideline & "emphasizes a modern, evidence-based approach to care" starting w/ screening & advancing through treatment. https://bit.ly/4596FiD #JACC #CardioSky #cvPAD

Modern cancer therapies heighten the importance of managing CV treatment-related complications. A new @accintouch.bsky.social CCG report outlines best practices for diagnosing & managing CV adverse effects from Bruton’s TKIs, ICIs & VEGF inhibitors https://bit.ly/4iYlLxq #JACC #CardioOnc #CardioSky

🚨 #ACC26 hits New Orleans Mar 28–30! Boost your research by publishing with #JACCJournals. 🗓️ Deadlines: • Jan 23 – oral/poster • Feb 15 – late-breakers Why #JACC? ⭐ Top-tier impact 🌍 Global reach ⚡ Easy submissions 📝 Preprint-friendly Submit today 🔗 https://bit.ly/3KKcHPU #CardioSky

Simplifying nutrition info can help consumers make healthier choices and lower #CVD risk, per new ACC guidance in #JACC. The guidance backs a standardized front-of-pack label highlighting key nutrients to limit or encourage. Get the details: https://bit.ly/4pMXfkK #CardioSky

DEADLINE EXTENDED! 🏀 #JACCCaseReports + #ACCSportsCardio are teaming up for a 2026 Sports Cardiology themed issue during March Madness & #ACC26. 🔗 Learn more & submit: https://www.jacc.org/call-for-papers/case-reports?utm_medium=social&utm_source=social_post&utm_campaign=social_post #SportsCardio

Finish the year strong with our final #JACCJournals Club! Earn last-minute CME as Caio De Assis Moura Tavares, MD, and Pedro A. Lemos, MD, PhD, break down key insights from their NEO-MINDSET substudy and what it means for the field. Save your spot: https://bit.ly/4pDq2YY #CardioSky #MedSky #AHA25

📸 JACC Journals were honored to join QICC 2025 in Hangzhou, China last week where leaders, including JACC Editor-in-Chief Dr. Harlan Krumholz, gathered to bridge global innovation in cardiovascular science. 🫀 Get the science published in #JACC here: https://bit.ly/48c9EHX #CardioSky #JACCJournals

The latest update from the #GBDStudy not only reveals the current state of #CVD on a global scale, but also points to the interventions that can help accelerate progress. This week's #JACC focus issue reflects on how these findings can guide the future of CV care. https://bit.ly/47Z4Nep #CardioSky

New HRS/ACC scientific statement outlines guiding principles for performing intracardiac ablation procedures in ASCs, highlighting their growing role, evidence for safe use in select patients, & key regulatory & operational standards. https://bit.ly/4psqysT #CardioSky #JACC #epAblation

#JACCJournals is honored to join QICC 2025, a leading global forum for CV science & innovation. Browse late-breaking trials, real-world insights, hands-on sessions & global collaboration shaping heart care’s future ❤️‍🩹🌏 https://bit.ly/48c9EHX #JACC #JACCINT #JACCCaseReports #CardioSky

86 families w/ hereditary #ATTR, cascade genetic screening identified a median of 2 carriers per proband, enabling earlier Dx & Tx. 1/3 of at-risk relatives were untested, showing the need to improve family screening. https://bit.ly/4paOdOs #amyloidosis #JACCCardioOnc #CardioOnc #CardioSky

New multi-society Advanced Training Statement on Advanced #cvImaging addresses the core competencies & training requirements necessary for advanced CV imagers across all 4 imaging modalities – echocardiography, CCT, nuclear cardiology & #CMR. Get the details: https://bit.ly/3M87z8p #JACC #CardioSky

Visceral fat is the hidden driver linking CKD and HFpEF. This Special Communication reframes adiposity as a pathogenic organ fueling renal and cardiac decline. #HFpEF #CKD More in the newest issue of #JACC: https://bit.ly/43ioRpq #CardioSky

Semaglutide works no matter your sex. In STRIDE, weekly 1.0 mg semaglutide improved walking function in PAD + T2D across men and women. But baseline differences show why sex-specific analysis still matters. Read more in new issue of #JACC: https://bit.ly/4fWwsik #CardioSky #GLP1

🫀 New ACC scientific statement in #JACC: Obesity drives risk for HF, CAD & #stroke, but targeted weight loss can change the game. Semaglutide & tirzepatide show promise in #HFpEF, but challenges remain. 🔗 Read the whole statement here: https://bit.ly/43qdfRg @accintouch.bsky.social#JACC#stroke#HFpEF#CardioSky

Current NT-proBNP thresholds miss high-BMI patients at risk. In pooled #HFpEF trials, those w/ severe obesity faced over twice the event rate despite “normal” values. It’s time to personalize BNP cutoffs. ⚖️ Explore more in the new issue of #JACC: https://bit.ly/3Lp3JaX #CardioSky

📊 New meta-analysis in #JACC: GLP-1 RAs reduced CV death, MACE & HF risk across 99K+ patients. ✅ Consistent benefits across diabetes, obesity, CKD & HF ⚠️ ↑ GI & gallbladder events 🎯 Personalize therapy by patient profile Read more in the new issue: https://bit.ly/4oHwWwn #CardioSky

Heart and liver, one metabolic disease. MASLD fuels cardiovascular risk through inflammation, insulin resistance and fat toxicity. Time for cardiologists to lead in diagnosis and prevention. More in the new issue of #JACC: https://bit.ly/3XiYxrB #cvMetabolic #cvPrev #CardioSky

🗨️ "Packer et al. advance a bold & thought-provoking thesis: that visceral adiposity, not hyperglycemia, is the dominant modifiable driver linking type 2 diabetes to HFpEF." -Drs. Krumholz & Inzucchi Read the entire Viewpoint in the newest issue of #JACC: https://bit.ly/4hSh0og #CardioSky

#Obesity changes everything about #PulmonaryEmbolism from diagnosis to drug dosing 💊. This review exposes how body size complicates imaging, therapy, and survival. Guidelines must catch up. 🆕 in #JACC: https://bit.ly/4ibq8ox #CardioSky

#AHA25 AFib shake-up 🫀⚡ OCEAN: post-ablation, rivaroxaban ↑ bleed, no stroke win vs aspirin → stop OAC ok. ADAPT/OPTIMA: post-stent, NOAC alone or 1-mo DAPT wins. CLOSURE: meds > LAAC in high-risk. Read more: shorturl.at/jVkk1 @jaccjournals.bsky.social @accintouch.bsky.social

Exciting science is live! 🚀 #JACCJournals are publishing top research from #AHA25 Scientific Sessions, with new papers across multiple journals showcasing some of the hottest trials and breakthroughs in cardiovascular medicine. Dive into the latest discoveries now: https://bit.ly/4o1EMkg #CardioSky

New ACC Concise Clinical Guidance updates best practices for diagnosing and managing transthyretin amyloid #cardiomyopathy, highlighting disease-modifying and HF therapies plus future directions. https://bit.ly/49nYX7m #JACC #Amyloidosis #ATTRCM #HeartFailure #CardioSky

🚨 #AI-based #ECG analysis significantly improved #STEMI detection, reduced false activations, and enhanced recognition of non-conventional presentations. This supports integration of AI-based ECG analysis into acute chest pain pathways. https://bit.ly/4hopPpT #TCT2025 #JACCINT #CardioSky

In the randomized PROCTOR trial, SVG #PCI was assoc with improved 1-yr clinical outcomes compared with native vessel PCI, primarily driven by lower rates of PCI-related MI & clinically driven target coronary territory #revascularization https://bit.ly/4ogyuxh #TCT2025 #JACC #cvMI #cvCABG #CardioSky

The STRIVE trial shows intracoronary low-dose alteplase doesn’t improve outcomes in #STEMI with large thrombus and may raise arrhythmic risk—closing the door on this adjunctive fibrinolysis strategy during primary #PCI. https://bit.ly/4oSfzc7 #TCT2025 #JACC #MACE #CardioSky

Despite Class I guideline indications, most patients with severe aortic regurgitation remain untreated. This #JACC review outlines advances in diagnosis, surgical refinements, and emerging transcatheter options to bridge this gap. https://bit.ly/3WPcVHM #TCT2025 #vhdAR #CardioSky

In patients with de novo coronary artery disease, #DCB angioplasty with rescue stenting was associated with a higher rate of Device-oriented Composite Endpoint compared to intended DES implantation regarding DoCE at 3 years. https://bit.ly/4nePRNp #TCT2025 #JACC #cvCAD #CardioSky

Findings from SUMMIT-MAC show that #TMVR using the Tendyne system significantly improved #heartfailure symptoms and QoL in patients with severe mitral annular calcification. Read the highlights: https://bit.ly/4qCxF3t #TCT2025 #JACC #CardioSky #MedSky @jaccjournals.bsky.social

In this first report of the primary outcomes of the SUMMIT-MAC clinical trial, #TMVR with Tendyne led to successful treatment of mitral valve disease due to MAC and significant improvements in #heartfailure symptoms and #QoL. https://bit.ly/4ovW0pz #TCT2025 #JACC #SUMMIT #CardioSky

🩸 New #JACCBTS study reveals estrogen’s dual effects on microvascular health differ by sex ⚖️ A balanced ceramide: S1P ratio is 🔑 to endothelial health 🧬 May explain why long-term hormone exposure can 📈 CV risk 🔗 https://bit.ly/43Ct5In #APSSexDiff2025 #CardioSky #MedSky

The DOSE Trial: In a multicenter RCT (n=1,001), operator radiation exposure was compared between left distal radial vs right transradial access at left wrist, head, and chest. No significant differences. https://bit.ly/43zuP59 #TCT2025 #JACC #CardioSky

FFR-guided #PCI using zotarolimus DES provides significantly better long-term value than CABG for treatment of patients with multivessel CAD, with equivalent clinical outcomes at substantially lower cost. https://bit.ly/47vJgJS #TCT2025 #JACC #cvCABG #cvCAD #CardioSky

Big ideas. Breakthrough science. Real-world impact 💡 The #JACCJournals family brings interventional innovation to #TCT2025, from late-breaking trials to transformative device advances 👉 https://bit.ly/3LhtZ6I #JACC #JACCINT #JACCCaseReports #JACCAdvances #CardioSky @crfheart.bsky.social#JACCJournals

Even small changes in #alcohol intake can impact #BP. 🍷➡️📉 Reducing or stopping drinking may lead to meaningful BP improvements and better management. https://bit.ly/43rOmEA #JACC #Hypertension #BloodPressure #CardioSky #MedSky

Big news for #JACCJournals! #JACCAsia and #JACCAdvances are approved for #ImpactFactor, with first rankings being issued in June. Launched in 2021 and 2022, respectively, both journals are shaping the future of #Cardiology. https://bit.ly/49d912U #CardioSky #MedSky @csilvers.bsky.social#JACCJournals

#JACCCardioOnc continues to rise, with a new Impact Factor of 13.4 and a top 10 ranking. The journal’s growing influence highlights its role as a leading platform for cutting-edge #CardioOnc research. https://bit.ly/43nTHwF #CardioSky #MedSky

#JACCCaseReports is in Denver for #ACCQuality25! Don’t miss the latest case studies released alongside the conference, showcasing innovative approaches to improving cardiovascular care: https://bit.ly/46SH9Qh #CardioEd #CardioSky

The latest issue of #JACC features Dr. Milton Packer’s exploration of the “#adipokine hypothesis,” linking adipocyte biology to #HFpEF. Along with commentaries, it also debuts an interactive tool for exploring molecular roles in HFpEF. Explore the issue: https://bit.ly/4obvBx0 #CardioSky #MedSky

In the sotalol-eligible patients, ablation led to lower risk of the primary composite endpoint. In the amiodarone-eligible group, efficacy outcomes were comparable between ablation and amiodarone. Adverse events were more marked among patients randomized to amiodarone. https://bit.ly/4mXfS3O #JACC